KPRX
Price
$3.27
Change
+$0.03 (+0.93%)
Updated
Dec 20 closing price
PTGX
Price
$41.41
Change
+$1.86 (+4.70%)
Updated
Dec 20, 04:59 PM (EDT)
85 days until earnings call
Ad is loading...

KPRX vs PTGX

Header iconKPRX vs PTGX Comparison
Open Charts KPRX vs PTGXBanner chart's image
Kiora Pharmaceuticals
Price$3.27
Change+$0.03 (+0.93%)
Volume$24.37K
CapitalizationN/A
Protagonist Therapeutics
Price$41.41
Change+$1.86 (+4.70%)
Volume$62.22K
CapitalizationN/A
KPRX vs PTGX Comparison Chart
Loading...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPRX vs. PTGX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPRX is a Hold and PTGX is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (KPRX: $3.27 vs. PTGX: $41.49)
Brand notoriety: KPRX and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPRX: 57% vs. PTGX: 335%
Market capitalization -- KPRX: $9.81M vs. PTGX: $2.47B
KPRX [@Biotechnology] is valued at $9.81M. PTGX’s [@Biotechnology] market capitalization is $2.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPRX’s FA Score shows that 3 FA rating(s) are green whilePTGX’s FA Score has 2 green FA rating(s).

  • KPRX’s FA Score: 3 green, 2 red.
  • PTGX’s FA Score: 2 green, 3 red.
According to our system of comparison, PTGX is a better buy in the long-term than KPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPRX’s TA Score shows that 3 TA indicator(s) are bullish while PTGX’s TA Score has 3 bullish TA indicator(s).

  • KPRX’s TA Score: 3 bullish, 6 bearish.
  • PTGX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both KPRX and PTGX are a bad buy in the short-term.

Price Growth

KPRX (@Biotechnology) experienced а -1.51% price change this week, while PTGX (@Biotechnology) price change was +1.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

KPRX is expected to report earnings on May 09, 2023.

PTGX is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($2.47B) has a higher market cap than KPRX($9.81M). PTGX has higher P/E ratio than KPRX: PTGX (15.14) vs KPRX (3.11). PTGX YTD gains are higher at: 80.942 vs. KPRX (-30.449). PTGX has higher annual earnings (EBITDA): 152M vs. KPRX (2.39M). PTGX has more cash in the bank: 469M vs. KPRX (29M). KPRX has less debt than PTGX: KPRX (72.6K) vs PTGX (10.9M). PTGX has higher revenues than KPRX: PTGX (324M) vs KPRX (16M).
KPRXPTGXKPRX / PTGX
Capitalization9.81M2.47B0%
EBITDA2.39M152M2%
Gain YTD-30.44980.942-38%
P/E Ratio3.1115.1421%
Revenue16M324M5%
Total Cash29M469M6%
Total Debt72.6K10.9M1%
FUNDAMENTALS RATINGS
KPRX vs PTGX: Fundamental Ratings
KPRX
PTGX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10041
SMR RATING
1..100
3322
PRICE GROWTH RATING
1..100
7742
P/E GROWTH RATING
1..100
421
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPRX's Valuation (21) in the Pharmaceuticals Other industry is somewhat better than the same rating for PTGX (65) in the Biotechnology industry. This means that KPRX’s stock grew somewhat faster than PTGX’s over the last 12 months.

PTGX's Profit vs Risk Rating (41) in the Biotechnology industry is somewhat better than the same rating for KPRX (100) in the Pharmaceuticals Other industry. This means that PTGX’s stock grew somewhat faster than KPRX’s over the last 12 months.

PTGX's SMR Rating (22) in the Biotechnology industry is in the same range as KPRX (33) in the Pharmaceuticals Other industry. This means that PTGX’s stock grew similarly to KPRX’s over the last 12 months.

PTGX's Price Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for KPRX (77) in the Pharmaceuticals Other industry. This means that PTGX’s stock grew somewhat faster than KPRX’s over the last 12 months.

KPRX's P/E Growth Rating (4) in the Pharmaceuticals Other industry is in the same range as PTGX (21) in the Biotechnology industry. This means that KPRX’s stock grew similarly to PTGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPRXPTGX
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
72%
View a ticker or compare two or three
Ad is loading...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRESX11.360.19
+1.70%
Goldman Sachs Real Estate Securities Svc
APDLX14.260.14
+0.99%
Artisan Value Advisor
JUSSX18.070.17
+0.95%
JPMorgan US Small Company L
FWWFX35.150.28
+0.80%
Fidelity Worldwide
RNWAX74.090.11
+0.15%
American Funds New World R1

KPRX and

Correlation & Price change

A.I.dvisor tells us that KPRX and FRES have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KPRX and FRES's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
+0.96%
FRES - KPRX
31%
Poorly correlated
-2.60%
AKTX - KPRX
30%
Poorly correlated
-2.99%
PTGX - KPRX
30%
Poorly correlated
+4.93%
TCRT - KPRX
29%
Poorly correlated
-2.97%
RCUS - KPRX
28%
Poorly correlated
+0.26%
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with ACLX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
+4.93%
ACLX - PTGX
41%
Loosely correlated
+0.44%
ARDX - PTGX
41%
Loosely correlated
+2.77%
BEAM - PTGX
40%
Loosely correlated
+8.04%
VRDN - PTGX
40%
Loosely correlated
+1.60%
REPL - PTGX
40%
Loosely correlated
+4.00%
More